Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.94989314 |
2 | negative regulation of cell killing (GO:0031342) | 5.94989314 |
3 | ribosomal small subunit assembly (GO:0000028) | 5.62481153 |
4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.28734876 |
5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.28734876 |
6 | modulation by symbiont of host immune response (GO:0052553) | 5.28734876 |
7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.28734876 |
8 | modulation by symbiont of host defense response (GO:0052031) | 5.28734876 |
9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.28734876 |
10 | detection of other organism (GO:0098543) | 4.92595376 |
11 | macrophage activation involved in immune response (GO:0002281) | 4.90734058 |
12 | detection of bacterium (GO:0016045) | 4.87147831 |
13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.59808785 |
14 | DNA deamination (GO:0045006) | 4.48438893 |
15 | neutrophil activation (GO:0042119) | 4.40097367 |
16 | cellular extravasation (GO:0045123) | 4.27093229 |
17 | viral transcription (GO:0019083) | 4.26405128 |
18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.24911929 |
19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.16494147 |
20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.16494147 |
21 | regulation of mast cell degranulation (GO:0043304) | 4.12369840 |
22 | translational termination (GO:0006415) | 4.06184492 |
23 | detection of external biotic stimulus (GO:0098581) | 4.05547028 |
24 | negative regulation of interleukin-12 production (GO:0032695) | 4.04758245 |
25 | granulocyte activation (GO:0036230) | 4.03255960 |
26 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.95642023 |
27 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.92958302 |
28 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.86846274 |
29 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.82853062 |
30 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.81257462 |
31 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.76032625 |
32 | positive regulation of mast cell activation (GO:0033005) | 3.71073721 |
33 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.70811166 |
34 | negative regulation of phagocytosis (GO:0050765) | 3.69556722 |
35 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.67662825 |
36 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.67282593 |
37 | response to host immune response (GO:0052572) | 3.67282593 |
38 | ribosomal small subunit biogenesis (GO:0042274) | 3.66539621 |
39 | immunoglobulin mediated immune response (GO:0016064) | 3.64934609 |
40 | regulation of leukocyte degranulation (GO:0043300) | 3.63800735 |
41 | translational elongation (GO:0006414) | 3.62396742 |
42 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.62334382 |
43 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.60817499 |
44 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.60685238 |
45 | response to interleukin-15 (GO:0070672) | 3.58884017 |
46 | cotranslational protein targeting to membrane (GO:0006613) | 3.57914548 |
47 | detection of biotic stimulus (GO:0009595) | 3.56567652 |
48 | protein targeting to ER (GO:0045047) | 3.55310368 |
49 | response to interferon-beta (GO:0035456) | 3.54865096 |
50 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.54656025 |
51 | positive thymic T cell selection (GO:0045059) | 3.52402826 |
52 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.51888730 |
53 | detection of molecule of bacterial origin (GO:0032490) | 3.51365319 |
54 | leukocyte aggregation (GO:0070486) | 3.50504980 |
55 | macrophage activation (GO:0042116) | 3.49824648 |
56 | positive regulation of B cell differentiation (GO:0045579) | 3.49513350 |
57 | DNA strand elongation (GO:0022616) | 3.48685156 |
58 | positive regulation of mast cell degranulation (GO:0043306) | 3.46672776 |
59 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.46672776 |
60 | microglial cell activation (GO:0001774) | 3.46488240 |
61 | regulation of mast cell activation (GO:0033003) | 3.46284072 |
62 | negative thymic T cell selection (GO:0045060) | 3.46194439 |
63 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.43632403 |
64 | maturation of SSU-rRNA (GO:0030490) | 3.43274571 |
65 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.40316801 |
66 | protein localization to endoplasmic reticulum (GO:0070972) | 3.40172131 |
67 | negative regulation of T cell mediated immunity (GO:0002710) | 3.38013879 |
68 | negative T cell selection (GO:0043383) | 3.36931591 |
69 | response to muramyl dipeptide (GO:0032495) | 3.36403426 |
70 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.36016492 |
71 | mast cell activation (GO:0045576) | 3.35738335 |
72 | response to host (GO:0075136) | 3.35737986 |
73 | response to host defenses (GO:0052200) | 3.35737986 |
74 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.35737986 |
75 | regulation of B cell differentiation (GO:0045577) | 3.34808937 |
76 | cellular response to interleukin-15 (GO:0071350) | 3.34529965 |
77 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.32691681 |
78 | cellular response to zinc ion (GO:0071294) | 3.32535348 |
79 | regulation of T cell tolerance induction (GO:0002664) | 3.31307161 |
80 | telomere maintenance via recombination (GO:0000722) | 3.31102661 |
81 | cellular response to interferon-beta (GO:0035458) | 3.27590671 |
82 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.25635739 |
83 | viral life cycle (GO:0019058) | 3.21793119 |
84 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.21769148 |
85 | B cell mediated immunity (GO:0019724) | 3.21294937 |
86 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.19007541 |
87 | regulation of tolerance induction (GO:0002643) | 3.18134483 |
88 | neutrophil activation involved in immune response (GO:0002283) | 3.17324629 |
89 | positive regulation of antigen processing and presentation (GO:0002579) | 3.15432367 |
90 | respiratory burst (GO:0045730) | 3.13068978 |
91 | regulation of antigen processing and presentation (GO:0002577) | 3.13016499 |
92 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.12925730 |
93 | cellular protein complex disassembly (GO:0043624) | 3.08483035 |
94 | translational initiation (GO:0006413) | 3.06817737 |
95 | defense response to protozoan (GO:0042832) | 3.06234397 |
96 | regulation of regulated secretory pathway (GO:1903305) | 3.05411915 |
97 | T cell selection (GO:0045058) | 3.04307971 |
98 | germinal center formation (GO:0002467) | 3.03094774 |
99 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.02863496 |
100 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.02863496 |
101 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.02534742 |
102 | B cell receptor signaling pathway (GO:0050853) | 3.01133562 |
103 | mitotic recombination (GO:0006312) | 2.99123767 |
104 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.97174141 |
105 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.93610904 |
106 | negative regulation of innate immune response (GO:0045824) | 2.93492979 |
107 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.93301327 |
108 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.92756690 |
109 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.92619433 |
110 | response to protozoan (GO:0001562) | 2.91127806 |
111 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.90434126 |
112 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.89878129 |
113 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.89878129 |
114 | DNA unwinding involved in DNA replication (GO:0006268) | 2.88771528 |
115 | platelet dense granule organization (GO:0060155) | 2.85089341 |
116 | mature B cell differentiation involved in immune response (GO:0002313) | 2.82659546 |
117 | DNA replication initiation (GO:0006270) | 2.82040858 |
118 | type I interferon signaling pathway (GO:0060337) | 2.81158029 |
119 | cellular response to type I interferon (GO:0071357) | 2.81158029 |
120 | response to type I interferon (GO:0034340) | 2.78552075 |
121 | telomere maintenance via telomere lengthening (GO:0010833) | 2.75280464 |
122 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.74741527 |
123 | response to peptidoglycan (GO:0032494) | 2.74565257 |
124 | myeloid dendritic cell activation (GO:0001773) | 2.73588190 |
125 | protein complex disassembly (GO:0043241) | 2.73299648 |
126 | definitive hemopoiesis (GO:0060216) | 2.69128948 |
127 | ribosomal large subunit biogenesis (GO:0042273) | 2.67691556 |
128 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.66891907 |
129 | mast cell degranulation (GO:0043303) | 2.64978002 |
130 | mast cell activation involved in immune response (GO:0002279) | 2.64978002 |
131 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.64085061 |
132 | NIK/NF-kappaB signaling (GO:0038061) | 2.63064610 |
133 | neutrophil mediated immunity (GO:0002446) | 2.60655134 |
134 | response to interferon-alpha (GO:0035455) | 2.59985085 |
135 | sequestering of actin monomers (GO:0042989) | 2.59400533 |
136 | T cell homeostasis (GO:0043029) | 2.58877149 |
137 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.58079886 |
138 | formation of translation preinitiation complex (GO:0001731) | 2.56871157 |
139 | actin nucleation (GO:0045010) | 2.56296786 |
140 | mature B cell differentiation (GO:0002335) | 2.56190131 |
141 | macromolecular complex disassembly (GO:0032984) | 2.55493766 |
142 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.55114615 |
143 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.55061978 |
144 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.54955193 |
145 | interferon-gamma production (GO:0032609) | 2.54898638 |
146 | pseudouridine synthesis (GO:0001522) | 2.52631733 |
147 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.52369134 |
148 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.52110043 |
149 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.51991010 |
150 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.51691835 |
151 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.51599391 |
152 | megakaryocyte development (GO:0035855) | 2.51487187 |
153 | positive regulation of lamellipodium assembly (GO:0010592) | 2.47672120 |
154 | positive regulation of interferon-alpha production (GO:0032727) | 2.45904354 |
155 | mRNA catabolic process (GO:0006402) | 2.45531680 |
156 | regulation of gamma-delta T cell activation (GO:0046643) | 2.44753402 |
157 | lymphoid progenitor cell differentiation (GO:0002320) | 2.44160950 |
158 | leukocyte degranulation (GO:0043299) | 2.44033283 |
159 | macrophage differentiation (GO:0030225) | 2.43359868 |
160 | endosome to melanosome transport (GO:0035646) | 2.41461175 |
161 | endosome to pigment granule transport (GO:0043485) | 2.41461175 |
162 | necroptotic process (GO:0070266) | 2.40881513 |
163 | T cell migration (GO:0072678) | 2.40204683 |
164 | RNA catabolic process (GO:0006401) | 2.37625920 |
165 | myeloid cell activation involved in immune response (GO:0002275) | 2.37248204 |
166 | IMP metabolic process (GO:0046040) | 2.36818538 |
167 | regulation of necroptotic process (GO:0060544) | 2.36435080 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.04147374 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.65630227 |
3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.26061825 |
4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.17315084 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.16333426 |
6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.01154871 |
7 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.91513286 |
8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.81709209 |
9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.81629236 |
10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.72906128 |
11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.56939511 |
12 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.48502515 |
13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.45586131 |
14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.43953676 |
15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.42345340 |
16 | MYC_22102868_ChIP-Seq_BL_Human | 2.39635055 |
17 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.35092875 |
18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.32497862 |
19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.32039207 |
20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.28884161 |
21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.28466184 |
22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.28321938 |
23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.27879397 |
24 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.26079554 |
25 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.18895378 |
26 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.17258423 |
27 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.14341570 |
28 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.07360689 |
29 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.05622861 |
30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.05539773 |
31 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.04494699 |
32 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.01738650 |
33 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01190012 |
34 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.95901968 |
35 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.92873369 |
36 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.90046748 |
37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.89058670 |
38 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.86999822 |
39 | MYB_26560356_Chip-Seq_TH2_Human | 1.86505042 |
40 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.85871770 |
41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.85243565 |
42 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.84389428 |
43 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.83351448 |
44 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78818059 |
45 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.77757612 |
46 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.77514719 |
47 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77231437 |
48 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.76574104 |
49 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.76405794 |
50 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.74780207 |
51 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.74703768 |
52 | * MAF_26560356_Chip-Seq_TH1_Human | 1.71981420 |
53 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.71849270 |
54 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.71499285 |
55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.71238019 |
56 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.71024947 |
57 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.68491684 |
58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.67025849 |
59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.64767992 |
60 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.60261439 |
61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59229676 |
62 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.58071999 |
63 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.57206527 |
64 | * MYB_26560356_Chip-Seq_TH1_Human | 1.56896356 |
65 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.55844754 |
66 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55358257 |
67 | UTX_26944678_Chip-Seq_JUKART_Human | 1.53731614 |
68 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.52551106 |
69 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.50981816 |
70 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.50902417 |
71 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.48262709 |
72 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.47949839 |
73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.44619658 |
74 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.44034108 |
75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.42661300 |
76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.42233901 |
77 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.40737434 |
78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39632042 |
79 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39476610 |
80 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38549581 |
81 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.37641998 |
82 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.37329646 |
83 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.37189208 |
84 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.36724383 |
85 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.35726661 |
86 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.34036125 |
87 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.33593830 |
88 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33560368 |
89 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.32612533 |
90 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30636066 |
91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29665785 |
92 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.29437262 |
93 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.29364804 |
94 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.28345966 |
95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27014316 |
96 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.26575343 |
97 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25860132 |
98 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.25604020 |
99 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.24507787 |
100 | GATA1_22025678_ChIP-Seq_K562_Human | 1.24401315 |
101 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22603581 |
102 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.21106272 |
103 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20948104 |
104 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.18925383 |
105 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.16425275 |
106 | MAF_26560356_Chip-Seq_TH2_Human | 1.16355067 |
107 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.15615752 |
108 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14540606 |
109 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.12380482 |
110 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.11786395 |
111 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.11663958 |
112 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11488025 |
113 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08528519 |
114 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08430543 |
115 | P68_20966046_ChIP-Seq_HELA_Human | 1.07233672 |
116 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.06447107 |
117 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.06144832 |
118 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05757931 |
119 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.05437958 |
120 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.05191572 |
121 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.04682220 |
122 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.04109859 |
123 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03932461 |
124 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03813502 |
125 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02320872 |
126 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01940450 |
127 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01855304 |
128 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01484772 |
129 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.99718156 |
130 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.99454248 |
131 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.99177528 |
132 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98233199 |
133 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97049107 |
134 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.96941695 |
135 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96572329 |
136 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.96189604 |
137 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92409384 |
138 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.91511196 |
139 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91217528 |
140 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91003254 |
141 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.90807546 |
142 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.90374505 |
143 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89081357 |
144 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87919708 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.39791667 |
2 | MP0002396_abnormal_hematopoietic_system | 3.73986943 |
3 | MP0009785_altered_susceptibility_to | 3.15860223 |
4 | MP0005671_abnormal_response_to | 3.15536556 |
5 | MP0000685_abnormal_immune_system | 2.97558315 |
6 | MP0003436_decreased_susceptibility_to | 2.86198507 |
7 | MP0003763_abnormal_thymus_physiology | 2.78532744 |
8 | MP0001800_abnormal_humoral_immune | 2.76773717 |
9 | MP0005025_abnormal_response_to | 2.64445434 |
10 | MP0005000_abnormal_immune_tolerance | 2.61773685 |
11 | MP0002148_abnormal_hypersensitivity_rea | 2.59578195 |
12 | MP0002452_abnormal_antigen_presenting | 2.58197342 |
13 | MP0002420_abnormal_adaptive_immunity | 2.53774870 |
14 | MP0001819_abnormal_immune_cell | 2.50775357 |
15 | MP0002398_abnormal_bone_marrow | 2.48391618 |
16 | MP0002419_abnormal_innate_immunity | 2.45035439 |
17 | MP0002723_abnormal_immune_serum | 2.44738704 |
18 | MP0002166_altered_tumor_susceptibility | 2.41583490 |
19 | MP0004808_abnormal_hematopoietic_stem | 2.41508489 |
20 | MP0005464_abnormal_platelet_physiology | 2.38665115 |
21 | MP0001790_abnormal_immune_system | 2.32919131 |
22 | MP0005387_immune_system_phenotype | 2.32919131 |
23 | MP0003693_abnormal_embryo_hatching | 2.29013631 |
24 | MP0000716_abnormal_immune_system | 2.15870385 |
25 | MP0009333_abnormal_splenocyte_physiolog | 2.13738003 |
26 | MP0005174_abnormal_tail_pigmentation | 2.12752836 |
27 | MP0000689_abnormal_spleen_morphology | 2.10749424 |
28 | MP0002006_tumorigenesis | 2.07086344 |
29 | MP0002722_abnormal_immune_system | 2.02895735 |
30 | MP0003724_increased_susceptibility_to | 2.01782248 |
31 | MP0001853_heart_inflammation | 1.99976458 |
32 | MP0001545_abnormal_hematopoietic_system | 1.97644639 |
33 | MP0005397_hematopoietic_system_phenotyp | 1.97644639 |
34 | MP0002405_respiratory_system_inflammati | 1.97134107 |
35 | MP0002429_abnormal_blood_cell | 1.94624980 |
36 | MP0010094_abnormal_chromosome_stability | 1.92178555 |
37 | MP0000490_abnormal_crypts_of | 1.82742970 |
38 | MP0005075_abnormal_melanosome_morpholog | 1.80731343 |
39 | MP0008260_abnormal_autophagy | 1.73900397 |
40 | MP0010155_abnormal_intestine_physiology | 1.73818784 |
41 | MP0003077_abnormal_cell_cycle | 1.72799420 |
42 | MP0008007_abnormal_cellular_replicative | 1.70767453 |
43 | MP0003303_peritoneal_inflammation | 1.66897651 |
44 | MP0000465_gastrointestinal_hemorrhage | 1.65166671 |
45 | MP0008057_abnormal_DNA_replication | 1.63679842 |
46 | MP0000703_abnormal_thymus_morphology | 1.63333747 |
47 | MP0001845_abnormal_inflammatory_respons | 1.60453563 |
48 | MP0001873_stomach_inflammation | 1.60166343 |
49 | MP0006054_spinal_hemorrhage | 1.53245007 |
50 | MP0000858_altered_metastatic_potential | 1.52785517 |
51 | MP0004957_abnormal_blastocyst_morpholog | 1.49727760 |
52 | MP0008058_abnormal_DNA_repair | 1.49295897 |
53 | MP0003806_abnormal_nucleotide_metabolis | 1.44086982 |
54 | MP0006082_CNS_inflammation | 1.43738649 |
55 | MP0002095_abnormal_skin_pigmentation | 1.40649265 |
56 | MP0000015_abnormal_ear_pigmentation | 1.35178595 |
57 | MP0003111_abnormal_nucleus_morphology | 1.33278714 |
58 | MP0003172_abnormal_lysosome_physiology | 1.31913985 |
59 | MP0001533_abnormal_skeleton_physiology | 1.31613616 |
60 | MP0002019_abnormal_tumor_incidence | 1.31253771 |
61 | MP0000343_altered_response_to | 1.28053724 |
62 | MP0003075_altered_response_to | 1.27057783 |
63 | MP0004510_myositis | 1.26622249 |
64 | MP0003866_abnormal_defecation | 1.26619051 |
65 | MP0008469_abnormal_protein_level | 1.23815105 |
66 | MP0005451_abnormal_body_composition | 1.20930485 |
67 | MP0002933_joint_inflammation | 1.19768748 |
68 | MP0005058_abnormal_lysosome_morphology | 1.17760251 |
69 | MP0009278_abnormal_bone_marrow | 1.16281226 |
70 | MP0004381_abnormal_hair_follicle | 1.15295938 |
71 | MP0002277_abnormal_respiratory_mucosa | 1.13831881 |
72 | MP0004947_skin_inflammation | 1.12276787 |
73 | MP0010352_gastrointestinal_tract_polyps | 1.10021044 |
74 | MP0004883_abnormal_blood_vessel | 1.08425971 |
75 | MP0005166_decreased_susceptibility_to | 1.00475653 |
76 | MP0000313_abnormal_cell_death | 0.96650150 |
77 | MP0003448_altered_tumor_morphology | 0.94123918 |
78 | MP0005164_abnormal_response_to | 0.88841738 |
79 | MP0003186_abnormal_redox_activity | 0.87333032 |
80 | MP0005310_abnormal_salivary_gland | 0.87305342 |
81 | MP0002132_abnormal_respiratory_system | 0.86046240 |
82 | MP0009379_abnormal_foot_pigmentation | 0.85958273 |
83 | MP0001986_abnormal_taste_sensitivity | 0.85890741 |
84 | MP0003300_gastrointestinal_ulcer | 0.83093274 |
85 | MP0000604_amyloidosis | 0.81632174 |
86 | MP0002138_abnormal_hepatobiliary_system | 0.80724927 |
87 | MP0009840_abnormal_foam_cell | 0.79252986 |
88 | MP0003183_abnormal_peptide_metabolism | 0.78864157 |
89 | MP0003943_abnormal_hepatobiliary_system | 0.78464654 |
90 | MP0003279_aneurysm | 0.78068868 |
91 | MP0000350_abnormal_cell_proliferation | 0.76808189 |
92 | MP0005023_abnormal_wound_healing | 0.74478704 |
93 | MP0010307_abnormal_tumor_latency | 0.74107359 |
94 | MP0003690_abnormal_glial_cell | 0.73046154 |
95 | MP0003786_premature_aging | 0.71753754 |
96 | MP0009765_abnormal_xenobiotic_induced | 0.66511236 |
97 | MP0008004_abnormal_stomach_pH | 0.66275866 |
98 | MP0003828_pulmonary_edema | 0.66184457 |
99 | MP0009763_increased_sensitivity_to | 0.66035443 |
100 | MP0000371_diluted_coat_color | 0.65866511 |
101 | MP0009764_decreased_sensitivity_to | 0.64794460 |
102 | MP0001663_abnormal_digestive_system | 0.63883880 |
103 | MP0008874_decreased_physiological_sensi | 0.63807910 |
104 | MP0001851_eye_inflammation | 0.63577068 |
105 | MP0005390_skeleton_phenotype | 0.62605728 |
106 | MP0000249_abnormal_blood_vessel | 0.58773291 |
107 | MP0005319_abnormal_enzyme/_coenzyme | 0.56352856 |
108 | MP0003191_abnormal_cellular_cholesterol | 0.55600089 |
109 | MP0000477_abnormal_intestine_morphology | 0.54877985 |
110 | MP0000358_abnormal_cell_content/ | 0.54706538 |
111 | MP0002075_abnormal_coat/hair_pigmentati | 0.54657310 |
112 | MP0008932_abnormal_embryonic_tissue | 0.54583454 |
113 | MP0008873_increased_physiological_sensi | 0.54052036 |
114 | MP0003656_abnormal_erythrocyte_physiolo | 0.53961774 |
115 | MP0004858_abnormal_nervous_system | 0.51509686 |
116 | MP0002998_abnormal_bone_remodeling | 0.51349683 |
117 | MP0002009_preneoplasia | 0.49852713 |
118 | MP0003795_abnormal_bone_structure | 0.48973802 |
119 | MP0004147_increased_porphyrin_level | 0.48592976 |
120 | MP0003045_fibrosis | 0.47385742 |
121 | MP0005084_abnormal_gallbladder_morpholo | 0.46581371 |
122 | MP0002693_abnormal_pancreas_physiology | 0.45607442 |
123 | MP0000609_abnormal_liver_physiology | 0.45069323 |
124 | MP0005381_digestive/alimentary_phenotyp | 0.43459223 |
125 | MP0005076_abnormal_cell_differentiation | 0.39708734 |
126 | MP0005376_homeostasis/metabolism_phenot | 0.38587939 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.34689209 |
2 | Recurrent abscess formation (HP:0002722) | 5.20511477 |
3 | Myositis (HP:0100614) | 4.74302096 |
4 | Thrombocytosis (HP:0001894) | 4.68530139 |
5 | Recurrent bacterial skin infections (HP:0005406) | 4.65597656 |
6 | IgM deficiency (HP:0002850) | 4.16328744 |
7 | Eczematoid dermatitis (HP:0000976) | 4.09946112 |
8 | Gastrointestinal infarctions (HP:0005244) | 3.80530071 |
9 | Aplastic anemia (HP:0001915) | 3.71575618 |
10 | Chronic otitis media (HP:0000389) | 3.68946776 |
11 | Increased IgE level (HP:0003212) | 3.54774647 |
12 | Reticulocytopenia (HP:0001896) | 3.52569880 |
13 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.50781791 |
14 | Abnormal number of erythroid precursors (HP:0012131) | 3.49775520 |
15 | Urticaria (HP:0001025) | 3.45799732 |
16 | Recurrent viral infections (HP:0004429) | 3.43240037 |
17 | Petechiae (HP:0000967) | 3.38356976 |
18 | Recurrent fungal infections (HP:0002841) | 3.38280160 |
19 | Recurrent bronchitis (HP:0002837) | 3.26985179 |
20 | Recurrent skin infections (HP:0001581) | 3.26382182 |
21 | Meningitis (HP:0001287) | 3.22940014 |
22 | Obstructive lung disease (HP:0006536) | 3.14625635 |
23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.14625635 |
24 | Panhypogammaglobulinemia (HP:0003139) | 3.13292416 |
25 | Mediastinal lymphadenopathy (HP:0100721) | 3.12757719 |
26 | Abnormality of T cell physiology (HP:0011840) | 3.04280364 |
27 | Cellulitis (HP:0100658) | 3.01634547 |
28 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.99982010 |
29 | Abnormality of macrophages (HP:0004311) | 2.92572171 |
30 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.89744273 |
31 | Recurrent cutaneous fungal infections (HP:0011370) | 2.89744273 |
32 | Orchitis (HP:0100796) | 2.88381680 |
33 | Keratoconjunctivitis (HP:0001096) | 2.88100725 |
34 | Abnormality of T cells (HP:0002843) | 2.87375713 |
35 | Increased IgM level (HP:0003496) | 2.86554281 |
36 | Hypochromic microcytic anemia (HP:0004840) | 2.85180902 |
37 | Abnormality of B cell number (HP:0010975) | 2.80653542 |
38 | B lymphocytopenia (HP:0010976) | 2.80653542 |
39 | Agammaglobulinemia (HP:0004432) | 2.79375109 |
40 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.77533730 |
41 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.77533730 |
42 | Abnormality of glycolipid metabolism (HP:0010969) | 2.77533730 |
43 | Anorexia (HP:0002039) | 2.75211370 |
44 | Hypochromic anemia (HP:0001931) | 2.74316170 |
45 | IgG deficiency (HP:0004315) | 2.72972467 |
46 | Prolonged bleeding time (HP:0003010) | 2.72267844 |
47 | Lymphopenia (HP:0001888) | 2.70839471 |
48 | Vasculitis (HP:0002633) | 2.68200600 |
49 | Type I transferrin isoform profile (HP:0003642) | 2.67552579 |
50 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.66249756 |
51 | Amyloidosis (HP:0011034) | 2.65734097 |
52 | Optic neuritis (HP:0100653) | 2.64401434 |
53 | Retrobulbar optic neuritis (HP:0100654) | 2.64401434 |
54 | Reduced antithrombin III activity (HP:0001976) | 2.63863022 |
55 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.60600691 |
56 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.59951432 |
57 | Gingival bleeding (HP:0000225) | 2.59763300 |
58 | Episodic fever (HP:0001954) | 2.58660403 |
59 | Agnosia (HP:0010524) | 2.58015855 |
60 | Abnormality of the prostate (HP:0008775) | 2.57532615 |
61 | Colitis (HP:0002583) | 2.53897421 |
62 | Lymphoma (HP:0002665) | 2.48763853 |
63 | Pulmonary embolism (HP:0002204) | 2.48289684 |
64 | Thyroiditis (HP:0100646) | 2.48203763 |
65 | Purpura (HP:0000979) | 2.47866504 |
66 | Increased cerebral lipofuscin (HP:0011813) | 2.45875441 |
67 | Sepsis (HP:0100806) | 2.45639511 |
68 | Hepatosplenomegaly (HP:0001433) | 2.44580074 |
69 | Arterial thrombosis (HP:0004420) | 2.44383413 |
70 | Granulocytopenia (HP:0001913) | 2.39957925 |
71 | Leukocytosis (HP:0001974) | 2.37373985 |
72 | Epistaxis (HP:0000421) | 2.35402505 |
73 | Interstitial pulmonary disease (HP:0006530) | 2.34256036 |
74 | Severe combined immunodeficiency (HP:0004430) | 2.33845974 |
75 | Pallor (HP:0000980) | 2.32433433 |
76 | Pustule (HP:0200039) | 2.31322681 |
77 | Increased serum ferritin (HP:0003281) | 2.30076540 |
78 | T lymphocytopenia (HP:0005403) | 2.27816525 |
79 | Gastrointestinal stroma tumor (HP:0100723) | 2.26918477 |
80 | Loss of speech (HP:0002371) | 2.26163648 |
81 | Abnormality of T cell number (HP:0011839) | 2.24959424 |
82 | Hemoptysis (HP:0002105) | 2.24737388 |
83 | Periodontitis (HP:0000704) | 2.23454407 |
84 | Eosinophilia (HP:0001880) | 2.23376148 |
85 | Nasal polyposis (HP:0100582) | 2.22424270 |
86 | Encephalitis (HP:0002383) | 2.20320603 |
87 | Abnormality of eosinophils (HP:0001879) | 2.19953292 |
88 | Disinhibition (HP:0000734) | 2.19260639 |
89 | Poikiloderma (HP:0001029) | 2.18785049 |
90 | Hypergammaglobulinemia (HP:0010702) | 2.17863924 |
91 | Spontaneous hematomas (HP:0007420) | 2.17530348 |
92 | Autoimmune thrombocytopenia (HP:0001973) | 2.17506383 |
93 | Gastrointestinal inflammation (HP:0004386) | 2.17270291 |
94 | Combined immunodeficiency (HP:0005387) | 2.17017984 |
95 | Recurrent pneumonia (HP:0006532) | 2.16627593 |
96 | Gangrene (HP:0100758) | 2.16155083 |
97 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.15893626 |
98 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.15893626 |
99 | Abnormal protein glycosylation (HP:0012346) | 2.15893626 |
100 | Abnormal glycosylation (HP:0012345) | 2.15893626 |
101 | Microcytic anemia (HP:0001935) | 2.15662119 |
102 | Stomatitis (HP:0010280) | 2.15106741 |
103 | Acute hepatic failure (HP:0006554) | 2.15060471 |
104 | Inflammation of the large intestine (HP:0002037) | 2.14453371 |
105 | Vacuolated lymphocytes (HP:0001922) | 2.13262524 |
106 | Glomerulopathy (HP:0100820) | 2.13252599 |
107 | Hypertensive crisis (HP:0100735) | 2.12339476 |
108 | Peritonitis (HP:0002586) | 2.11826055 |
109 | Abnormality of the nasal mucosa (HP:0000433) | 2.11181223 |
110 | Osteomyelitis (HP:0002754) | 2.11166480 |
111 | Dysostosis multiplex (HP:0000943) | 2.11118589 |
112 | Birth length less than 3rd percentile (HP:0003561) | 2.10749056 |
113 | Pulmonary fibrosis (HP:0002206) | 2.07865704 |
114 | Acute myeloid leukemia (HP:0004808) | 2.07724300 |
115 | Abnormality of iron homeostasis (HP:0011031) | 2.06589004 |
116 | Amaurosis fugax (HP:0100576) | 2.06070197 |
117 | Recurrent lower respiratory tract infections (HP:0002783) | 2.05179238 |
118 | Myelodysplasia (HP:0002863) | 2.02351660 |
119 | Recurrent sinusitis (HP:0011108) | 2.02140756 |
120 | Abnormality of the peritoneum (HP:0002585) | 2.02005211 |
121 | Keratoconjunctivitis sicca (HP:0001097) | 2.01500474 |
122 | Hypoplasia of the thymus (HP:0000778) | 2.01019566 |
123 | 11 pairs of ribs (HP:0000878) | 2.00133640 |
124 | Basal ganglia calcification (HP:0002135) | 1.99340604 |
125 | Poor head control (HP:0002421) | 1.98772686 |
126 | Pulmonary infiltrates (HP:0002113) | 1.98660063 |
127 | Gingivitis (HP:0000230) | 1.97665192 |
128 | Skin ulcer (HP:0200042) | 1.96328978 |
129 | Macrocytic anemia (HP:0001972) | 1.95822866 |
130 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.95475425 |
131 | Skin rash (HP:0000988) | 1.94985798 |
132 | Papilloma (HP:0012740) | 1.94916482 |
133 | Verrucae (HP:0200043) | 1.94916482 |
134 | Autoimmune hemolytic anemia (HP:0001890) | 1.94472144 |
135 | Chest pain (HP:0100749) | 1.93174227 |
136 | Abnormality of the pleura (HP:0002103) | 1.92014058 |
137 | Abnormal platelet function (HP:0011869) | 1.91257984 |
138 | Upper motor neuron abnormality (HP:0002127) | 1.90974763 |
139 | Systemic lupus erythematosus (HP:0002725) | 1.89888324 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.13168251 |
2 | KIT | 3.43278512 |
3 | NME2 | 2.77110653 |
4 | TXK | 2.56449116 |
5 | IRAK4 | 2.56125130 |
6 | STK16 | 2.52566234 |
7 | BLK | 2.52143623 |
8 | FLT3 | 2.51406331 |
9 | TEC | 2.44860577 |
10 | TNK2 | 2.30578683 |
11 | CSF1R | 2.25864361 |
12 | BTK | 2.17797686 |
13 | PRPF4B | 2.12197881 |
14 | ZAP70 | 2.12001933 |
15 | MAP3K12 | 2.04907182 |
16 | TYK2 | 2.02962455 |
17 | JAK3 | 1.98195902 |
18 | WEE1 | 1.95770098 |
19 | TBK1 | 1.90326471 |
20 | MAP3K3 | 1.77692266 |
21 | ACVR1B | 1.74844753 |
22 | IKBKE | 1.71949424 |
23 | PIM2 | 1.69669475 |
24 | SYK | 1.66460010 |
25 | KDR | 1.60750805 |
26 | TESK2 | 1.53693189 |
27 | TAOK1 | 1.52594543 |
28 | EPHB1 | 1.50731485 |
29 | EIF2AK3 | 1.46381042 |
30 | TGFBR1 | 1.44945207 |
31 | MAP2K3 | 1.42782371 |
32 | RPS6KA4 | 1.42329093 |
33 | VRK1 | 1.38548938 |
34 | FGR | 1.36572631 |
35 | MAP3K13 | 1.33553246 |
36 | CDC7 | 1.33168537 |
37 | EIF2AK1 | 1.32362103 |
38 | BUB1 | 1.31133140 |
39 | MAP3K14 | 1.26480026 |
40 | BCKDK | 1.19814492 |
41 | IKBKB | 1.17729150 |
42 | ERN1 | 1.17317625 |
43 | LYN | 1.17137687 |
44 | LRRK2 | 1.16474805 |
45 | BRSK2 | 1.16345484 |
46 | MAP3K1 | 1.16135457 |
47 | TAOK2 | 1.16066754 |
48 | EEF2K | 1.15257719 |
49 | LCK | 1.15092916 |
50 | STK10 | 1.14140223 |
51 | CLK1 | 1.13442557 |
52 | JAK2 | 1.08959877 |
53 | RIPK4 | 1.07513827 |
54 | MARK3 | 1.06437070 |
55 | CCNB1 | 1.04964123 |
56 | SCYL2 | 1.04857302 |
57 | FES | 1.03943118 |
58 | MATK | 1.03672171 |
59 | ITK | 0.99572258 |
60 | PIM1 | 0.96364302 |
61 | HCK | 0.96258667 |
62 | TRIB3 | 0.95541847 |
63 | NLK | 0.94017352 |
64 | SMG1 | 0.92694084 |
65 | TGFBR2 | 0.91972924 |
66 | PRKD2 | 0.88375788 |
67 | GRK6 | 0.88321854 |
68 | PKN2 | 0.87154661 |
69 | CDK8 | 0.86657286 |
70 | ADRBK2 | 0.85418045 |
71 | TNIK | 0.85354482 |
72 | PDK1 | 0.83887367 |
73 | BMPR2 | 0.82987342 |
74 | MAP3K11 | 0.82615216 |
75 | RPS6KB2 | 0.82319785 |
76 | CAMKK2 | 0.81327867 |
77 | CDK7 | 0.77680866 |
78 | MKNK1 | 0.77455253 |
79 | CDK19 | 0.77213947 |
80 | ATR | 0.77151695 |
81 | PASK | 0.77036289 |
82 | IRAK3 | 0.76155308 |
83 | MAPK12 | 0.75329432 |
84 | NEK2 | 0.73015504 |
85 | SIK3 | 0.71952518 |
86 | PDPK1 | 0.71606253 |
87 | YES1 | 0.70468593 |
88 | DAPK1 | 0.70152623 |
89 | PAK4 | 0.70087329 |
90 | MARK2 | 0.69044043 |
91 | MYLK | 0.68204545 |
92 | PTK6 | 0.67559463 |
93 | CDK4 | 0.67188755 |
94 | JAK1 | 0.65835710 |
95 | MAP3K6 | 0.65591371 |
96 | FGFR4 | 0.65346925 |
97 | DYRK3 | 0.63759445 |
98 | TLK1 | 0.63583125 |
99 | TESK1 | 0.63170743 |
100 | FYN | 0.63069495 |
101 | TSSK6 | 0.63028814 |
102 | CSK | 0.62755289 |
103 | KSR2 | 0.61837285 |
104 | PRKCQ | 0.61363042 |
105 | RPS6KA6 | 0.58949892 |
106 | IRAK2 | 0.58586770 |
107 | SRPK1 | 0.56514735 |
108 | MAP3K10 | 0.56181298 |
109 | MAP3K8 | 0.54716834 |
110 | GRK7 | 0.54662407 |
111 | ILK | 0.54541819 |
112 | MAP2K2 | 0.53389913 |
113 | IRAK1 | 0.53198030 |
114 | MAPK7 | 0.50991074 |
115 | STK4 | 0.50560811 |
116 | RPS6KC1 | 0.49877816 |
117 | RPS6KL1 | 0.49877816 |
118 | TAOK3 | 0.49412827 |
119 | SIK2 | 0.48833361 |
120 | CDC42BPA | 0.48511847 |
121 | PTK2B | 0.48316659 |
122 | MAPKAPK2 | 0.48287243 |
123 | SIK1 | 0.46803385 |
124 | FGFR3 | 0.46722860 |
125 | NEK9 | 0.46490169 |
126 | MAP3K5 | 0.46010457 |
127 | AURKB | 0.45184470 |
128 | MAPK4 | 0.43646549 |
129 | HIPK2 | 0.43035489 |
130 | BRSK1 | 0.42473176 |
131 | RAF1 | 0.41204974 |
132 | PRKG2 | 0.40997831 |
133 | EIF2AK2 | 0.40494479 |
134 | PIK3CG | 0.40149304 |
135 | MAPKAPK3 | 0.39687072 |
136 | CHUK | 0.38328751 |
137 | PRKCD | 0.36762271 |
138 | PLK1 | 0.36428054 |
139 | MAP2K6 | 0.36152519 |
140 | MAP2K4 | 0.35320581 |
141 | MAP3K7 | 0.35041716 |
142 | ARAF | 0.34201256 |
143 | RPS6KA2 | 0.33865542 |
144 | MOS | 0.33445842 |
145 | STK11 | 0.33276351 |
146 | CAMKK1 | 0.31397299 |
147 | DYRK1B | 0.29478967 |
148 | MAPK11 | 0.29265595 |
149 | ABL1 | 0.28771990 |
150 | PRKCH | 0.27267518 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 4.04112789 |
2 | Ribosome_Homo sapiens_hsa03010 | 3.56179556 |
3 | Mismatch repair_Homo sapiens_hsa03430 | 3.03045967 |
4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.90454907 |
5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.82155881 |
6 | Base excision repair_Homo sapiens_hsa03410 | 2.52415487 |
7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.27061322 |
8 | Homologous recombination_Homo sapiens_hsa03440 | 2.18680218 |
9 | Proteasome_Homo sapiens_hsa03050 | 2.18295116 |
10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.16272884 |
11 | Spliceosome_Homo sapiens_hsa03040 | 1.91848467 |
12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.91367522 |
13 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.90635514 |
14 | Measles_Homo sapiens_hsa05162 | 1.76882128 |
15 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.75086368 |
16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.73925788 |
17 | RNA polymerase_Homo sapiens_hsa03020 | 1.73663444 |
18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.70189136 |
19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.66392842 |
20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.65646392 |
21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.63031167 |
22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.60896919 |
23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.60504670 |
24 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.58496657 |
25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.56761268 |
26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.50973293 |
27 | Legionellosis_Homo sapiens_hsa05134 | 1.42920765 |
28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.38199793 |
29 | Cell cycle_Homo sapiens_hsa04110 | 1.36615560 |
30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.28193174 |
31 | Shigellosis_Homo sapiens_hsa05131 | 1.26542406 |
32 | Other glycan degradation_Homo sapiens_hsa00511 | 1.23844286 |
33 | RNA transport_Homo sapiens_hsa03013 | 1.20401554 |
34 | Allograft rejection_Homo sapiens_hsa05330 | 1.19567129 |
35 | Pertussis_Homo sapiens_hsa05133 | 1.17669089 |
36 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13682263 |
37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.13310464 |
38 | RNA degradation_Homo sapiens_hsa03018 | 1.13006764 |
39 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.12560314 |
40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.11904937 |
41 | Protein export_Homo sapiens_hsa03060 | 1.11892038 |
42 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.09530304 |
43 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.08262104 |
44 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.06995441 |
45 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.06880824 |
46 | Influenza A_Homo sapiens_hsa05164 | 1.06707638 |
47 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.05419080 |
48 | Hepatitis B_Homo sapiens_hsa05161 | 1.05010482 |
49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.02742808 |
50 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.01743910 |
51 | Malaria_Homo sapiens_hsa05144 | 1.00238490 |
52 | Asthma_Homo sapiens_hsa05310 | 0.99714991 |
53 | Apoptosis_Homo sapiens_hsa04210 | 0.98941265 |
54 | Tuberculosis_Homo sapiens_hsa05152 | 0.98743876 |
55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96427750 |
56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95917269 |
57 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.95046044 |
58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.94006435 |
59 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.93748067 |
60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.93380747 |
61 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.93346656 |
62 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.92195696 |
63 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91882777 |
64 | Viral myocarditis_Homo sapiens_hsa05416 | 0.91274763 |
65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.89155931 |
66 | Platelet activation_Homo sapiens_hsa04611 | 0.85936525 |
67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84140045 |
68 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.83119730 |
69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.82891307 |
70 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.81834491 |
71 | Purine metabolism_Homo sapiens_hsa00230 | 0.79746776 |
72 | Salmonella infection_Homo sapiens_hsa05132 | 0.78660808 |
73 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.77796967 |
74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76360437 |
75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75949384 |
76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75032867 |
77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71828874 |
78 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.71175373 |
79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71008412 |
80 | Basal transcription factors_Homo sapiens_hsa03022 | 0.70146460 |
81 | Endocytosis_Homo sapiens_hsa04144 | 0.69627796 |
82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69352996 |
83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.67892199 |
84 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64549504 |
85 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64313989 |
86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.61103884 |
87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59625854 |
88 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57241890 |
89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55604226 |
90 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55093237 |
91 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.54963997 |
92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54841747 |
93 | Thyroid cancer_Homo sapiens_hsa05216 | 0.54002391 |
94 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53441839 |
95 | Lysosome_Homo sapiens_hsa04142 | 0.52911218 |
96 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52541707 |
97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49846206 |
98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49239652 |
99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49084013 |
100 | Phagosome_Homo sapiens_hsa04145 | 0.48578838 |
101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48168763 |
102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47116455 |
103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45776069 |
104 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44311389 |
105 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43801655 |
106 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.42672142 |
107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42060625 |
108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41511413 |
109 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41093231 |
110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40462695 |
111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39681290 |
112 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.38910533 |
113 | Hepatitis C_Homo sapiens_hsa05160 | 0.38882714 |
114 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38562969 |
115 | Amoebiasis_Homo sapiens_hsa05146 | 0.38322048 |
116 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.37995354 |
117 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.37978514 |
118 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.36863500 |
119 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34745210 |
120 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.32892451 |
121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32060750 |
122 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.30593765 |
123 | Insulin resistance_Homo sapiens_hsa04931 | 0.29682146 |
124 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.28679885 |
125 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.28057628 |
126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.27812616 |
127 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.26857198 |
128 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26203792 |
129 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25073629 |
130 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24099404 |
131 | Bladder cancer_Homo sapiens_hsa05219 | 0.24089070 |
132 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.23107646 |